Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison S Fiscalini

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Cancer Survivorship : Research and Practice|May 7, 2018
An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantationKaren L Syrjala, Jean C Yi, Samantha B Artherholt, et al.
JAMA Oncology|May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM StudyYiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
JAMA|December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical TrialLaura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Cancer Survivorship : Research and Practice|May 7, 2018
An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantationKaren L Syrjala, Jean C Yi, Samantha B Artherholt, et al.
JAMA Oncology|May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM StudyYiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
JAMA|December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical TrialLaura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Pageof 1